Clinical Trial Update: Optimal Duration of Olanzapine Add-on Therapy in Major Depression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the optimal duration of add-on olanzapine therapy in major depressive disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Relapse Rate of a Major Depressive Episode, Safety of Olanzapine in Subjects With Major Depression | Phase 3 | Status: WITHDRAWN